Table 1 Sequence results and clinicopathological information of chondrosarcomas used for metabolomics analysis
From: Mutant IDH and non-mutant chondrosarcomas display distinct cellular metabolomes
Genotype | Mutation | Tumor grade | Chondrosarcoma subtype | Metastatic status | Recurrence |
|---|---|---|---|---|---|
IDH1/2-WT | WT | 2 | Central | No Metastasis | No |
IDH1/2-WT | WT | 2 | Central | No Metastasis | No |
IDH1/2-WT | WT | 2 | Central | No Metastasis | No |
IDH1/2-WT | WT | 1 | Central | No Metastasis | No |
Mutant IDH1 | R132C | 3 | Central | Later Metastasis | Yes |
Mutant IDH1 | R132C | 3 | Central | Later Metastasis | Yes |
Mutant IDH1 | R132C | 2 | Central | No Metastasis | No |
Mutant IDH1 | R132C | 3 | Central | No Metastasis | No |
Mutant IDH1 | R132G | 1 | Clear Cell | Later Metastasis | Yes |
Mutant IDH1 | R132G | 2 | Dedifferentiated | Later Metastasis | Yes |
Mutant IDH1 | R132H | 3 | Clear Cell | Metastasis at Presentation | No |
Mutant IDH1 | R132H | 3 | Dedifferentiated | Metastasis at Presentation | No |
Mutant IDH2 | R172G | 3 | Dedifferentiated | Later Metastasis | Yes |
Mutant IDH2 | R172M | 3 | Dedifferentiated | Metastasis at Presentation | No |
Mutant IDH2 | R172M | 3 | Dedifferentiated | Metastasis at Presentation | No |
Mutant IDH2 | R172S | 3 | Dedifferentiated | Later Metastasis | Yes |
Mutant IDH2 | R172S | 3 | Dedifferentiated | Metastasis at Presentation | No |